MoneyWorks4Me

Caplin Point to sell Caplin Point Laboratories Colombia SAS to Caplin Point Far East

29 Mar 2023 Evaluate

Caplin Point Laboratories has entered into a Share Purchase agreement on March 28, 2023 for the sale of Caplin Point Laboratories Colombia SAS - Colombia, a subsidiary of the Company to Caplin Point Far East, Hong Kong, a wholly owned subsidiary of the Company.

Pursuant to execution of the Share Purchase Agreement and transfer of shares, Caplin Point Laboratories Colombia SAS - Colombia will cease to be a subsidiary of the company and shall become a step down subsidiary of the Company through Caplin Point Far East, Hong Kong.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

Caplin Point Labs. Share Price

2480.60 -17.65 (-0.71%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: